A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures - PubMed (original) (raw)
Review
. 2012 Apr;17(4):389-401.
doi: 10.1038/mp.2011.165. Epub 2011 Dec 6.
Affiliations
- PMID: 22143005
- PMCID: PMC3317062
- DOI: 10.1038/mp.2011.165
Review
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
D A Rossignol et al. Mol Psychiatry. 2012 Apr.
Abstract
Recent studies have implicated physiological and metabolic abnormalities in autism spectrum disorders (ASD) and other psychiatric disorders, particularly immune dysregulation or inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures ('four major areas'). The aim of this study was to determine trends in the literature on these topics with respect to ASD. A comprehensive literature search from 1971 to 2010 was performed in these four major areas in ASD with three objectives. First, publications were divided by several criteria, including whether or not they implicated an association between the physiological abnormality and ASD. A large percentage of publications implicated an association between ASD and immune dysregulation/inflammation (416 out of 437 publications, 95%), oxidative stress (all 115), mitochondrial dysfunction (145 of 153, 95%) and toxicant exposures (170 of 190, 89%). Second, the strength of evidence for publications in each area was computed using a validated scale. The strongest evidence was for immune dysregulation/inflammation and oxidative stress, followed by toxicant exposures and mitochondrial dysfunction. In all areas, at least 45% of the publications were rated as providing strong evidence for an association between the physiological abnormalities and ASD. Third, the time trends in the four major areas were compared with trends in neuroimaging, neuropathology, theory of mind and genetics ('four comparison areas'). The number of publications per 5-year block in all eight areas was calculated in order to identify significant changes in trends. Prior to 1986, only 12 publications were identified in the four major areas and 51 in the four comparison areas (42 for genetics). For each 5-year period, the total number of publications in the eight combined areas increased progressively. Most publications (552 of 895, 62%) in the four major areas were published in the last 5 years (2006-2010). Evaluation of trends between the four major areas and the four comparison areas demonstrated that the largest relative growth was in immune dysregulation/inflammation, oxidative stress, toxicant exposures, genetics and neuroimaging. Research on mitochondrial dysfunction started growing in the last 5 years. Theory of mind and neuropathology research has declined in recent years. Although most publications implicated an association between the four major areas and ASD, publication bias may have led to an overestimation of this association. Further research into these physiological areas may provide insight into general or subset-specific processes that could contribute to the development of ASD and other psychiatric disorders.
Figures
Figure 1
Graph of publications on autism spectrum disorder (ASD) by type and year of publication. (a) The number of publications in the eight areas per 5-year block on a logarithmic scale. (b) The proportion of publications within each research area normalized by the total number of publications within the specific research area. This allows the relative growth in each research area to be observed. (c) The proportion that each research area accounts for in the total number of publications identified for each specific 5-year period. This allows the relative influence of each area of research to be determined over time.
Similar articles
- Redox metabolism abnormalities in autistic children associated with mitochondrial disease.
Frye RE, Delatorre R, Taylor H, Slattery J, Melnyk S, Chowdhury N, James SJ. Frye RE, et al. Transl Psychiatry. 2013 Jun 18;3(6):e273. doi: 10.1038/tp.2013.51. Transl Psychiatry. 2013. PMID: 23778583 Free PMC article. - Environmental toxicants and autism spectrum disorders: a systematic review.
Rossignol DA, Genuis SJ, Frye RE. Rossignol DA, et al. Transl Psychiatry. 2014 Feb 11;4(2):e360. doi: 10.1038/tp.2014.4. Transl Psychiatry. 2014. PMID: 24518398 Free PMC article. Review. - Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.
Rossignol DA, Frye RE. Rossignol DA, et al. Mol Psychiatry. 2012 Mar;17(3):290-314. doi: 10.1038/mp.2010.136. Epub 2011 Jan 25. Mol Psychiatry. 2012. PMID: 21263444 Free PMC article. Review. - Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder.
Bradstreet JJ, Smith S, Baral M, Rossignol DA. Bradstreet JJ, et al. Altern Med Rev. 2010 Apr;15(1):15-32. Altern Med Rev. 2010. PMID: 20359266 Review. - Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
Frye RE, Melnyk S, Macfabe DF. Frye RE, et al. Transl Psychiatry. 2013 Jan 22;3(1):e220. doi: 10.1038/tp.2012.143. Transl Psychiatry. 2013. PMID: 23340503 Free PMC article.
Cited by
- The Pivotal Role of Aldehyde Toxicity in Autism Spectrum Disorder: The Therapeutic Potential of Micronutrient Supplementation.
Jurnak F. Jurnak F. Nutr Metab Insights. 2016 Jun 14;8(Suppl 1):57-77. doi: 10.4137/NMI.S29531. eCollection 2015. Nutr Metab Insights. 2016. PMID: 27330305 Free PMC article. - Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders.
Theoharides TC, Tsilioni I, Patel AB, Doyle R. Theoharides TC, et al. Transl Psychiatry. 2016 Jun 28;6(6):e844. doi: 10.1038/tp.2016.77. Transl Psychiatry. 2016. PMID: 27351598 Free PMC article. Review. - An ontology for Autism Spectrum Disorder (ASD) to infer ASD phenotypes from Autism Diagnostic Interview-Revised data.
Mugzach O, Peleg M, Bagley SC, Guter SJ, Cook EH, Altman RB. Mugzach O, et al. J Biomed Inform. 2015 Aug;56:333-47. doi: 10.1016/j.jbi.2015.06.026. Epub 2015 Jul 4. J Biomed Inform. 2015. PMID: 26151311 Free PMC article. - Sulforaphane treatment for autism spectrum disorder: A systematic review.
McGuinness G, Kim Y. McGuinness G, et al. EXCLI J. 2020 Jun 26;19:892-903. doi: 10.17179/excli2020-2487. eCollection 2020. EXCLI J. 2020. PMID: 33013262 Free PMC article. Review. - Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.
Severance EG, Gressitt KL, Halling M, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Alaedini A, Dupont D, Dickerson FB, Yolken RH. Severance EG, et al. Neurobiol Dis. 2012 Dec;48(3):447-53. doi: 10.1016/j.nbd.2012.07.005. Epub 2012 Jul 16. Neurobiol Dis. 2012. PMID: 22801085 Free PMC article.
References
- APA Diagnostic and Statistical Manual of Mental Disorders4th edn.American Psychiatric Association: Washington, DC; 1994
- Rice C. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ. 2009;58:1–20. - PubMed
- Schaefer GB, Mendelsohn NJ. Genetics evaluation for the etiologic diagnosis of autism spectrum disorders. Genet Med. 2008;10:4–12. - PubMed
- Buie T, Campbell DB, Fuchs GJ, III, Furuta GT, Levy J, Vandewater J, et al. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics. 2010;125 (Suppl 1:S1–18. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical